279 related articles for article (PubMed ID: 31172530)
1. Autophagy markers LC3 and p62 accumulate in immune-mediated necrotizing myopathy.
Girolamo F; Lia A; Annese T; Giannini M; Amati A; D'Abbicco D; Tampoia M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Trojano M
Muscle Nerve; 2019 Sep; 60(3):315-327. PubMed ID: 31172530
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
Gherardi RK
Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
[TBL] [Abstract][Full Text] [Related]
3. Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies.
Fischer N; Preuße C; Radke J; Pehl D; Allenbach Y; Schneider U; Feist E; von Casteleyn V; Hahn K; Ruck T; Meuth SG; Goebel HH; Graf R; Mammen A; Benveniste O; Stenzel W
Brain Pathol; 2020 Mar; 30(2):261-271. PubMed ID: 31376301
[TBL] [Abstract][Full Text] [Related]
4. Immune-Mediated Necrotizing Myopathy.
Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
Das L; Blumbergs PC; Manavis J; Limaye VS
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
[TBL] [Abstract][Full Text] [Related]
6. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
[TBL] [Abstract][Full Text] [Related]
7. [Idiopathic inflammatory myopathies. A review].
Acosta I; Matamala JM; Jara P; Pino F; Gallardo A; Verdugo R
Rev Med Chil; 2019 Mar; 147(3):342-355. PubMed ID: 31344172
[TBL] [Abstract][Full Text] [Related]
8. [The effect of interferon-gamma on skeletal muscle cell biology].
Hou C; Baba-Amer Y; Bencze M; Relaix F; Jérôme Authier F
Med Sci (Paris); 2018 Nov; 34 Hors série n°2():35-38. PubMed ID: 30418144
[TBL] [Abstract][Full Text] [Related]
9. Polymyositis: an overdiagnosed entity.
van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
[TBL] [Abstract][Full Text] [Related]
10. PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited.
Knauss S; Preusse C; Allenbach Y; Leonard-Louis S; Touat M; Fischer N; Radbruch H; Mothes R; Matyash V; Böhmerle W; Endres M; Goebel HH; Benveniste O; Stenzel W
Neurol Neuroimmunol Neuroinflamm; 2019 May; 6(3):e558. PubMed ID: 31044146
[TBL] [Abstract][Full Text] [Related]
11. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile.
Preuße C; Goebel HH; Held J; Wengert O; Scheibe F; Irlbacher K; Koch A; Heppner FL; Stenzel W
Am J Pathol; 2012 Dec; 181(6):2161-71. PubMed ID: 23058368
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis of primary inflammatory myopathies].
Benveniste O; Squier W; Boyer O; Hilton-Jones D; Herson S
Presse Med; 2004 Nov; 33(20):1444-50. PubMed ID: 15611679
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
15. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
16. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis.
Pinal-Fernandez I; Casal-Dominguez M; Derfoul A; Pak K; Miller FW; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Carrion-Ribas C; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
Ann Rheum Dis; 2020 Sep; 79(9):1234-1242. PubMed ID: 32546599
[TBL] [Abstract][Full Text] [Related]
17. Immune Mediated Necrotizing Myopathy: Where do we Stand?
Mohammed AGA; Gcelu A; Moosajee F; Botha S; Kalla AA
Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846
[TBL] [Abstract][Full Text] [Related]
18. The geoepidemiology of autoimmune muscle disease.
Prieto S; Grau JM
Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
[TBL] [Abstract][Full Text] [Related]
19. Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum.
Zierer LK; Naegel S; Schneider I; Kendzierski T; Kleeberg K; Koelsch AK; Scholle L; Schaefer C; Naegel A; Zierz S; Otto M; Stoltenburg-Didinger G; Kraya T; Stoevesandt D; Mensch A
J Neurol; 2024 Jun; 271(6):3186-3202. PubMed ID: 38438820
[TBL] [Abstract][Full Text] [Related]
20. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
